Literature DB >> 1988223

Lactoferrin-inducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity.

J A McCormick1, G M Markey, T C Morris.   

Abstract

Monocyte-enriched and lymphocyte-enriched fractions of peripheral blood from three healthy volunteers were obtained by percoll density gradient centrifugation. The cytotoxic activity of each fraction against 51Cr-labelled K562 cells was quantified in a 2-h assay using freshly isolated cells of each fraction and cells of each fraction which had been incubated with and without lactoferrin in complete medium for 18 h before performing the assay. We have thereby shown that cytotoxicity was not demonstrable in the lymphocyte fraction (containing 7.3 +/- 2% large granular lymphocytes) after 18 h in medium, whereas the cytotoxicity of the monocyte fraction (containing 3 +/- 0.4% large granular lymphocytes) was still significantly increased (P less than or equal to 0.01) and that lactoferrin had no effect on lymphocyte fraction cytotoxicity while producing an 11-fold increase in the cytotoxicity of the monocyte fraction. It is therefore possible to perform a relatively simple test of monocyte cytotoxicity using lactoferrin as a stimulant in a 2-h 51Cr-labelled K562 assay system by allowing 18 h to elapse for lymphocyte natural killer cytotoxicity to decay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988223      PMCID: PMC1535459          DOI: 10.1111/j.1365-2249.1991.tb05606.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines.

Authors:  Z L Chang; T Hoffman; H C Stevenson; G Trinchieri; R B Herberman
Journal:  Scand J Immunol       Date:  1983-11       Impact factor: 3.487

2.  Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.

Authors:  D A Horwitz; A C Bakke; W Abo; K Nishiya
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

3.  The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.

Authors:  B Freundlich; G Trinchieri; B Perussia; R B Zurier
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

4.  Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes.

Authors:  M Malkovský; B Loveland; M North; G L Asherson; L Gao; P Ward; W Fiers
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

5.  Spontaneous cytotoxicity by monocyte-enriched subpopulations of human peripheral blood mononuclear cells against human or mouse anchorage-dependent tumour cell lines. Contribution of NK-like cells.

Authors:  Z L Chang; T Hoffman; E Bonvini; H C Stevenson; R B Herberman
Journal:  Scand J Immunol       Date:  1983-11       Impact factor: 3.487

6.  Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.

Authors:  K Nishiya; D A Horwitz
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Monoclonal antibody-defined surface markers of effector cells involved in human monocyte cytotoxicity.

Authors:  A Villa; G Peri; V Rossi; D Delia; A Mantovani
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

  7 in total
  7 in total

Review 1.  Biological role of lactoferrin.

Authors:  L Sánchez; M Calvo; J H Brock
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

2.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity.

Authors:  K Shimizu; H Matsuzawa; K Okada; S Tazume; S Dosako; Y Kawasaki; K Hashimoto; Y Koga
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  A cytotoxic effect of human lactoferrin fusion with Fc domain of IgG.

Authors:  Ewa Zaczyńska; Maja Kocięba; Jolanta Artym; Iwona Kochanowska; Marian L Kruzel; Michał Zimecki
Journal:  Biometals       Date:  2022-09-22       Impact factor: 3.378

5.  Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine: Presentation of a Novel Therapeutic Approach.

Authors:  Rasool Choopani; Mehrzad Mehrbani; Alireza Fekri; Mitra Mehrabani
Journal:  J Evid Based Complementary Altern Med       Date:  2015-08-09

6.  Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat.

Authors:  Y Ushida; K Sekine; T Kuhara; N Takasuka; M Iigo; M Maeda; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1999-03

7.  Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.

Authors:  K Sekine; E Watanabe; J Nakamura; N Takasuka; D J Kim; M Asamoto; V Krutovskikh; H Baba-Toriyama; T Ota; M A Moore; M Masuda; H Sugimoto; H Nishino; T Kakizoe; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1997-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.